Metropolitan Life Insurance Company (MetLife)’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RARX Stock Details RARX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell
2020 Q1	$509K	Hold
2019 Q4	$497K	Hold
2019 Q3	$251K	Buy
2019 Q2	$197K	Buy
2019 Q1	$123K	Hold
2018 Q4	$100K	Buy
2017 Q3	–	Sell
2017 Q2	$166K	Buy